Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06636708 · ClinicalTrials.gov registry record · Phase 4
Efficacy of Nanodropper-mediated Topical Anesthetic
A Phase 4 study, sponsored by Columbia University.
- Completed
- Registry status
- Phase 4
- Development phase
- 56
- Enrollment target
NCT06636708 is a Phase 4 study that has completed, run by Columbia University. The registered enrollment target is 56 participants.
The verdict
NCT06636708, a Phase 4 study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 56 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to compare the onset and duration of numbness of the surface of the eye following the administration of numbing drops, called proparacaine, using either a standard eye drop bottle or a "Nanodropper" adaptor. The Nanodropper is designed to administer smaller-sized drops, or microdrops. Participants will: 1. Complete a baseline eye exam. 2. Receive a numbing drop using a standard dropper in one eye and the Nanodropper in the other eye. 3. Have their eyes tested for numbness at specific time points (30 seconds, 1, 2, 5, and 10 minutes after getting the drops). 4. Tell the researchers if they feel pain during the eye sensation tests. 5. Complete a survey about their experience with the eyedrops and testing procedure. This study could help us find a way to use less medication while still effectively administering eye medications, potentially saving money and reducing medical waste.
Interventions
- COMBINATION_PRODUCT Nanodropper and Proparacaine HCl 0.5%
- COMBINATION_PRODUCT Standard Eye Drop Bottle with Proparacaine HCl 0.5%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2024-12-12 |
| Est. Completion | 2025-04-24 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06636708
The ClinicalTrials.gov registry entry for NCT06636708 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nanodropper and Proparacaine HCl 0.5% is the first listed.
NCT06636708 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06636708 about?
NCT06636708 is a clinical study titled "Efficacy of Nanodropper-mediated Topical Anesthetic". The goal of this clinical trial is to compare the onset and duration of numbness of the surface of the eye following the administration of numbing drops, called proparacaine, using either a standard eye drop bottle or a "Nanodropper" adaptor. The Nanodropper is designed to administer smaller-sized d...
What is the current status of trial NCT06636708?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 56 participants. The study started on 2024-12-12. Estimated completion is 2025-04-24.
What interventions are being tested in trial NCT06636708?
The interventions under investigation include: Nanodropper and Proparacaine HCl 0.5% (COMBINATION_PRODUCT), Standard Eye Drop Bottle with Proparacaine HCl 0.5% (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT06636708?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.